Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2025 May 17];5(6):s38. Available from: https://skin.dermsquared.com/skin/article/view/1389